The most common endocrine illness in children and adolescents is type 1 diabetes. It is distinguished by a lack of insulin synthesis and necessitates daily insulin injections to keep glucose levels under control. As a result, there are numerous medical approaches to its management, such as levels of glycosylated haemoglobin (HbA1c) as a marker of glycemic control during the previous three months and monitoring of blood glucose levels, which affect the patient's mental health and quality of life. Type 1 diabetes complications and poor quality of life are widespread. Diabetes therapy is difficult during puberty and adolescence. Adolescents with T1D have poor metabolic control and a higher rate of acute complications. Because the onset of adolescence is frequently associated with decreased adherence to therapy and an increased risk of psychological illnesses.

Inclusion Criteria:

1. Both males and females were included.
2. Age ranges from 10 to 19 years.
3. Willing of the parents or the caregivers to participate in the study.
4. Duration of T1DM of at least 1 year.

Exclusion Criteria

1. Adolescents with an intelligence quotient below 70.
2. Adolescents with a history of substance use or psychiatric disorders.
3. Adolescents with medical or other neurological conditions.

This study will be screening for adolescents with diabetes mellitus